ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 888 filers reported holding ISHARES TR in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,532,661 | -11.1% | 20,710 | -7.7% | 0.07% | -26.7% |
| Q2 2023 | $2,847,878 | -6.3% | 22,431 | -4.7% | 0.09% | -10.9% |
| Q1 2023 | $3,038,786 | -5.8% | 23,527 | -4.2% | 0.10% | -8.2% |
| Q4 2022 | $3,225,429 | +10.0% | 24,567 | -2.0% | 0.11% | +5.8% |
| Q3 2022 | $2,931,000 | -36.6% | 25,063 | -36.2% | 0.10% | -33.3% |
| Q2 2022 | $4,624,000 | -70.9% | 39,309 | -67.8% | 0.16% | -65.0% |
| Q1 2022 | $15,901,000 | -17.2% | 122,033 | -3.0% | 0.45% | -10.4% |
| Q4 2021 | $19,203,000 | -11.0% | 125,821 | -5.7% | 0.50% | -18.5% |
| Q3 2021 | $21,571,000 | -0.8% | 133,421 | +0.4% | 0.61% | -2.9% |
| Q2 2021 | $21,751,000 | +4.7% | 132,914 | -3.7% | 0.63% | -3.7% |
| Q1 2021 | $20,772,000 | -39.4% | 137,975 | -39.0% | 0.65% | -42.2% |
| Q4 2020 | $34,251,000 | +11.6% | 226,092 | -0.3% | 1.13% | -2.1% |
| Q3 2020 | $30,703,000 | +1.5% | 226,742 | +2.4% | 1.15% | -4.8% |
| Q2 2020 | $30,255,000 | +27.4% | 221,340 | +0.5% | 1.21% | +2.8% |
| Q1 2020 | $23,740,000 | -13.0% | 220,342 | -2.7% | 1.18% | +8.9% |
| Q4 2019 | $27,290,000 | +9.9% | 226,458 | -9.2% | 1.08% | -0.9% |
| Q3 2019 | $24,827,000 | -8.7% | 249,521 | +0.1% | 1.09% | -11.4% |
| Q2 2019 | $27,198,000 | +12.0% | 249,291 | +14.8% | 1.23% | -29.2% |
| Q1 2019 | $24,275,000 | +21.8% | 217,133 | +5.0% | 1.74% | +9.6% |
| Q4 2018 | $19,936,000 | -25.9% | 206,743 | -6.3% | 1.59% | -16.0% |
| Q3 2018 | $26,905,000 | +4.5% | 220,639 | -0.2% | 1.89% | +0.8% |
| Q2 2018 | $25,757,000 | +10.9% | 220,980 | +1.6% | 1.87% | +3.0% |
| Q1 2018 | $23,224,000 | +1.7% | 217,578 | +1.7% | 1.82% | +0.2% |
| Q4 2017 | $22,843,000 | -2.0% | 213,949 | +206.1% | 1.82% | -9.2% |
| Q3 2017 | $23,316,000 | +5.3% | 69,893 | +1.6% | 2.00% | +6.2% |
| Q2 2017 | $22,136,000 | +8.5% | 68,786 | +0.6% | 1.88% | +4.7% |
| Q1 2017 | $20,395,000 | +22.6% | 68,378 | +9.1% | 1.80% | +11.7% |
| Q4 2016 | $16,629,000 | +26.4% | 62,659 | +37.9% | 1.61% | +2.4% |
| Q3 2016 | $13,157,000 | +27.4% | 45,452 | +13.2% | 1.57% | +23.2% |
| Q2 2016 | $10,331,000 | +4890.8% | 40,144 | +7068.6% | 1.28% | +4460.7% |
| Q2 2015 | $207,000 | – | 560 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |